Lira Pharma SRL
Lira Pharma reported total assets of €2.72m at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Aug 2026).
The score of Lira Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +68 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lira Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Aug 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Lira Pharma's financial analysis
- Solvency52.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lira Pharma
Lira Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0685.498.505
- VAT number
- BE0685498505
- Peppol
- Registered · 0208:0685498505 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Nov 2017
- Registered office
- 2280 Grobbendonk
- Latest accounts
- 2025 · filed on 18 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Lira Pharma (SRL) has been based in Grobbendonk since 2017, active in: activities of holding companies. For 2025, it reports a net profit of 210,951 € and equity of €1.44m; its revenue is not published. Its solvency stands at 52.8%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Lira Pharma
Companies in the same business, of comparable size and area, outside its group.
- Immodan Activities of holding companies Asse · balance sheet €2.73m
- Maeijens Activities of holding companies Eeklo · balance sheet €2.72m
- BDK Holding Activities of holding companies Menen · balance sheet €2.72m
- Maxim Hanssens Activities of holding companies Lendelede · balance sheet €2.72m
- Decoprint International Activities of holding companies Kortrijk · balance sheet €2.72m
- Integra Partners Activities of holding companies Ghent · balance sheet €2.72m
- A.A.C. Invest Activities of holding companies Ronse · balance sheet €2.72m
- ShadowMen Activities of holding companies Haacht · balance sheet €2.72m
Frequently asked questions about Lira Pharma
What is the revenue of Lira Pharma?
Lira Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lira Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0685498505 for Lira Pharma, if the company is VAT-registered. Its company number (CBE) is 0685.498.505.
Where is the registered office of Lira Pharma?
According to the CBE register, the registered office of Lira Pharma is in 2280 Grobbendonk.
What is the equity of Lira Pharma?
At the close of the 2025 financial year, the equity of Lira Pharma amounts to 1,437,857 €, a solvency of 52.8% of total assets.
Who manages Lira Pharma?
The register lists 2 active mandates at Lira Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lira Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →